CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 86 enrolled
Drug / intervention
ColActive Plus Collagen Matrix Dressingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06283173
NCT06283173N/ACompleted

Human Repeat Insult Patch Test (HRIPT): Assessment of Primary and Cumulative Skin Irritation and Skin Sensitization of a Product, Under Controlled and Maximized Conditions

Covalon Technologies Inc.·interventional·Posted Feb 28, 2024·Updated Mar 12, 2025

In Brief

A clinical study evaluating ColActive Plus Collagen Matrix Dressing for Skin Sensitisation. Completed, enrolled 86 participants across 1 site.

Detailed Summary

The objectives of this study are to determine by repetitive epidermal contact, the primary or cumulative irritation and the allergic contact sensitization potential of the ColActive Plus Collagen Matrix Dressing, under maximized conditions, with controlled product quantity and application site.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 28, 2024
Enrollment StartJan 31, 2024
Primary CompletionMar 22, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.3 years ago

Interventions

ColActive Plus Collagen Matrix Dressingdevice

Induction phase: Test article applied with Hill Top chamber every 48+ hours over 3 weeks. Rest phase: 10-day rest period with no application. Challenge phase: Test article applied for 48 hours and evaluated through 48 hours post removal. The positive control is evaluated at Induction 1 only. The negative control is applied following the same schedule as the test article.